Influence of neoadjuvant chemotherapy on outcomes of immediate breast reconstruction

Plastic and Reconstructive Surgery

Volumn 126, Issue 1, 2010, Pages 1-11

  Azzawi, Khayam ^a,b   Ismail, Amir ^a,b   Earl, Helena ^a,b   Forouhi, Parto ^a,b   Malata, Charles M ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST RECONSTRUCTION; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; MASTECTOMY; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE CARE; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954626703     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181da8699     Document Type: Article

References (57)

1. Bostwick J III. Breast reconstruction following mastectomy. CA Cancer J Clin. 1995;45:289-304.
2. Miller MJ. Immediate breast reconstruction. Clin Plast Surg. 1998;25:145-156.
3. Ringberg A, Tengrup I, Aspegren K, Palmer B. Immediate breast reconstruction after mastectomy for cancer. Eur J Surg Oncol. 1999;25:470-476.
4. Malata CM, McIntosh SA, Purushotham AD. Immediate breast reconstruction after mastectomy for cancer. Br J Surg. 2000;87:1455-1472.
5. Noone RB, Frazier TG, Hayward CZ, Skiles MS. Patient acceptance of immediate reconstruction following mastectomy. Plast Reconstr Surg. 1982;69:632-640.
6. Al-Ghazal SK, Sully L, Fallowfield L, Blamey RW. The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol. 2000;26:17-19.
7. Singletary SE. Skin-sparing mastectomy with immediate breast reconstruction: The M. D. Anderson Cancer Center experience. Ann Surg Oncol. 1996;3:411-416.
8. Carlson GW, Bostwick J III, Styblo T, et al. Skin-sparing mastectomy: Oncologic and reconstructive considerations. Ann Surg. 1997;225:570-575.
9. Simmons RM, Fish SK, Gayle L, et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Ann Surg Oncol. 1999; 6:676-681.
10. Langstein HN, Cheng MH, Singletary SE, et al. Breast cancer recurrence after immediate reconstruction: Patterns and significance. Plast Reconstr Surg. 2003;111:712-720; discussion 721-722.
11. Spiegel AJ, Butler CE. Recurrence following treatment of ductal carcinoma in situ with skin-sparing mastectomy and immediate breast reconstruction. Plast Reconstr Surg. 2003; 111:706-711.
12. Mustonen P, Lepistö J, Papp A, et al. The surgical and oncological safety of immediate breast reconstruction. Eur J Surg Oncol. 2004;30:817-823.
13. Sandelin K, Wickman M, Billgren AM. Oncological outcome after immediate breast reconstruction for invasive breast cancer: A long-term study. Breast 2004;13:210-218.
14. Taylor CW, Horgan K, Dodwell D. Oncological aspects of breast reconstruction. Breast 2005;14:118-130.
15. Jacquillat C, Auclerc G, Khayat D, et al. The role of neoadjuvant chemotherapy in breast cancers (in French). Pathol Biol (Paris) 1990;38:851-852.
16. Kaufmann M, Hortobagyi GN, Goldhirsch A, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update. J Clin Oncol. 2006;24:1940-1949.
17. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672-2685.
18. Kaufmann M, von Minckwitz G, Smith R, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: Review and recommendations. J Clin Oncol. 2003;21:2600-2608.
19. Gray R, Clarke M, Collins R, Peto R. The EBCTCG overview of adjuvant therapy of breast cancer. What are the implications for future studies? Early Breast Cancer Trialists' Collaborative Group. Ann N Y Acad Sci. 1993;698:339-348.
20. von Minckwitz G. Breakthrough for neoadjuvant chemotherapy. Breast Cancer 2008;15:27-30.
21. Scholl SM, Asselain B, Palangie T, et al. Neoadjuvant chemotherapy in operable breast cancer. Eur J Cancer 1991;27: 1668-1671.
22. Deutsch MF, Smith M, Wang B, Ainsle N, Schusterman MA. Immediate breast reconstruction with the TRAM flap after neoadjuvant therapy. Ann Plast Surg. 1999;42:240-244.
23. Gouy S, Rouzier R, Missana MC, Atallah D, Youssef O, Barreau-Pouhaer L. Immediate reconstruction after neoadjuvant chemotherapy: Effect on adjuvant treatment starting and survival. Ann Surg Oncol. 2005;12:161-166.
24. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455-1461.
25. Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18: 1668-1675.
26. Caffo O, Cazzolli D, Scalet A, et al. Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer. Breast Cancer Res Treat. 2000;60:267-275.
27. Rastogi P, Anderson SJ, Bear H, et al. Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol. 2008; 26:778-785.
28. Earl H, Vallier A-L, Hiller L, et al. Neo-tAnGo: A neoadjuvant randomised phase III trial of epirubicin/cyclophosphamide and paclitaxel- gemcitabine in the treatment of women with high-risk early breast cancer (EBC): First report of the primary endpoint, pathological complete response (pCR) (Abstract 522). 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition). 2009;27 (May 20 Supplement):15S.
29. Evans TR, Yellowlees A, Foster E, et al. Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: An anglo-celtic cooperative oncology group study. J Clin Oncol. 2005;23:2988-2995.
30. Mehrara BJ, Santoro TD, Arcilla E, Watson JP, Shaw WW, Da Lio AL. Complications after microvascular breast reconstruction: Experience with 1195 flaps. Plast Reconstr Surg. 2006; 118:1100-1109.
31. Forouhi P, Dixon JM, Leonard RC, Chetty U. Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer. Br J Surg. 1995;82:79-82.
32. Gargan TJ, Come SE, Satwicz PR. Breast cancer chemotherapy: Perioperative considerations in breast reconstruction. Plast Reconstr Surg. 1985;75:430-434.
33. Woodworth PA, McBoyle MF, Helmer SD, Beamer RL. Seroma formation after breast cancer surgery: Incidence and predicting factors. Am Surg. 2000;66:444-450; discussion 450-451.
34. Gill PS, Hunt JP, Guerra A, et al. A 10-year retrospective review of 758 DIEP flaps for breast reconstruction. Plast Reconstr Surg. 2004;113:1153-1160.
35. Selber JC, Kurichi JE, Vega SJ, Sonnad SS, Serletti JM. Risk factors and complications in free TRAM flap breast reconstruction. Ann Plast Surg. 2006;56:492-497.
36. Bonadonna G. Conceptual and practical advances in the management of breast cancer. J Clin Oncol. l989;7:1380-1397.
37. Ang PT, Buzdar AU, Smith TL, Kau S, Hortobagyi GN. Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma. J Clin Oncol. l989;7:1677-1684.
38. Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. J Surg Oncol. 2002;80:4-11.
39. Smith I, Chua S. Medical treatment of early breast cancer: IV. Neoadjuvant treatment. BMJ. 2006;332:223-224. (Pubitemid 43171705)
40. Kim R, Osaki A, Toge T. Current and future roles of neoadjuvant chemotherapy in operable breast cancer. Clin Breast Cancer 2005;6:223-232; discussion 233-234.
41. Cameron DA, Gregory WM, Bowman A, et al. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response. Br J Cancer 2000;83:98-103.
42. Papa MZ, Zippel D, Kaufman B, et al. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol. 2008;98:403-406.
43. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI. Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys. 2006;65:1353-1360.
44. Kronowitz SJ, Kuerer HM. Advances and surgical decisionmaking for breast reconstruction. Cancer 2006;107:893-907.
45. Whitfield GA, Horan G, Irwin MS, Malata CM, Wishart GC, Wilson CB. Incidence of severe capsular contracture following implant-based immediate breast reconstruction with or without postoperative chest wall radiotherapy using 40 Gray in 15 fractions. Radiother Oncol. 2009;90:141-147.
46. Hodgson EL, Malata CM. Implant-based breast reconstruction following mastectomy. Breast Dis. 2002;16:47-63.
47. Spear SL, Onyewu C. Staged breast reconstruction with saline-filled implants in the irradiated breast: Recent trends and therapeutic implications. Plast Reconstr Surg. 2000;105: 930-942.
48. Javaid M, Song F, Leinster S, Dickson MG, James NK. Radiation effects on the cosmetic outcomes of immediate and delayed autologous breast reconstruction: An argument about timing. J Plast Reconstr Aesthet Surg. 2006;59:16-26.
49. Fodor J, Gulyas G, Polgar C, Major T, Kasler M. Radiotherapy and breast reconstruction: The issue of compatibility. Orv Hetil. 2003;144:549-555.
50. Spear SL, Ducic I, Low M, Cuoco F. The effect of radiation on pedicled TRAM flap breast reconstruction: Outcomes and implications. Plast Reconstr Surg. 2005;115:84-95.
51. Tran NV, Evans GR, Kroll S, et al. Postoperative adjuvant irradiation: Effects on transverse rectus abdominis muscle flap breast reconstruction. Plast Reconstr Surg. 2000;106:313-317; discussion 318-320. (Pubitemid 30640450)
52. Carlson GW, Page AL, Peters K, Ashinoff R, Schaefer T, Losken A. Effects of radiation therapy on pedicled transverse rectus abdominis myocutaneous flap breast reconstruction. Ann Plast Surg. 2008;60:568-572. (Pubitemid 351591467)
53. Tran NV, Chang DW, Gupta A, Kroll SS, Rob GL. Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg. 2001;108:78-82.
54. Rogers NE, Allen RJ. Radiation effects on breast reconstruction with the deep inferior epigastric perforator flap. Plast Reconstr Surg. 2002;109:1919-1926.
55. Hussein M, Salah B, Malyon A, Wieler-Mithoff EM. The effect of radiotherapy on the use of immediate breast reconstruction. Eur J Surg Oncol. 2004;30:490-494.
56. Kronowitz SJ, Hunt KK, Kuerer H, et al. Delayed-immediate breast reconstruction. Plast Reconstr Surg. 2004;113:1617-1628.
57. Kronowitz SJ, Robb GL. Controversies regarding immediate reconstruction: Aesthetic risks of radiation. In: Spear SL, ed. Surgery of the Breast: Principles and Art. Philadelphia: Lippincott Williams & Wilkins; 2006:679-699.